Breast Cancer Detection
Breast Cancer Detection
Breast Cancer Detection
Two-tier, affordable screening that blends conversational AI risk assessment with AI-assisted mammography to find breast cancer earlier at scale in India.
Two-tier, affordable screening that blends conversational AI risk assessment with AI-assisted mammography to find breast cancer earlier at scale in India.
Two-tier, affordable screening that blends conversational AI risk assessment with AI-assisted mammography to find breast cancer earlier at scale in India.
Overview
Overview
Overview
Breast cancer remains one of India’s most critical health challenges, with nearly 2 lakh new cases diagnosed every year, accounting for 30% of all cancer cases in the country. Alarmingly, its incidence has risen by 46% over the past two decades. Despite this growing burden, India continues to rely heavily on Clinical Breast Examination (CBE) for screening, as access to imaging technologies and trained radiologists, particularly in Tier-2/3 cities and rural regions, remains limited. This dependence often leads to delayed detection and poorer outcomes for patients.
Breast cancer remains one of India’s most critical health challenges, with nearly 2 lakh new cases diagnosed every year, accounting for 30% of all cancer cases in the country. Alarmingly, its incidence has risen by 46% over the past two decades. Despite this growing burden, India continues to rely heavily on Clinical Breast Examination (CBE) for screening, as access to imaging technologies and trained radiologists, particularly in Tier-2/3 cities and rural regions, remains limited. This dependence often leads to delayed detection and poorer outcomes for patients.
Breast cancer remains one of India’s most critical health challenges, with nearly 2 lakh new cases diagnosed every year, accounting for 30% of all cancer cases in the country. Alarmingly, its incidence has risen by 46% over the past two decades. Despite this growing burden, India continues to rely heavily on Clinical Breast Examination (CBE) for screening, as access to imaging technologies and trained radiologists, particularly in Tier-2/3 cities and rural regions, remains limited. This dependence often leads to delayed detection and poorer outcomes for patients.
Risk Predictors
Risk Predictors
Risk Predictors
Age, family and maternal history, along with menstrual and reproductive patterns, influence lifetime hormone exposure and inherited risk, affecting a person’s likelihood of developing breast cancer.
Ethnicity further shapes this risk profile, with some population groups experiencing higher incidence or more aggressive disease types.
Age, family and maternal history, along with menstrual and reproductive patterns, influence lifetime hormone exposure and inherited risk, affecting a person’s likelihood of developing breast cancer.
Ethnicity further shapes this risk profile, with some population groups experiencing higher incidence or more aggressive disease types.
Age, family and maternal history, along with menstrual and reproductive patterns, influence lifetime hormone exposure and inherited risk, affecting a person’s likelihood of developing breast cancer.
Ethnicity further shapes this risk profile, with some population groups experiencing higher incidence or more aggressive disease types.
Solution
Solution
Solution
Data Collection Flow
Data Collection Flow
Data Collection Flow
We received ethics committee approval in January 2026 and CTRI registration: CTRI/2026/04/108575 in April 2026. As part of the data collection workflow, participants first review a consent page, and depending on their choice, we either record only mammography details or, if consent is given, capture a structured risk questionnaire (lifestyle, breast examination, family history) followed by mammography data.
We received ethics committee approval in January 2026 and CTRI registration: CTRI/2026/04/108575 in April 2026. As part of the data collection workflow, participants first review a consent page, and depending on their choice, we either record only mammography details or, if consent is given, capture a structured risk questionnaire (lifestyle, breast examination, family history) followed by mammography data.
We received ethics committee approval in January 2026 and CTRI registration: CTRI/2026/04/108575 in April 2026. As part of the data collection workflow, participants first review a consent page, and depending on their choice, we either record only mammography details or, if consent is given, capture a structured risk questionnaire (lifestyle, breast examination, family history) followed by mammography data.
AI enabled Breast Cancer Risk Prediction Tool
AI enabled Breast Cancer Risk Prediction Tool
AI enabled Breast Cancer Risk Prediction Tool
Team & Collaborators
Team & Collaborators
Team & Collaborators
Principal Investigator
Principal Investigator
Principal Investigator
Phaneendra K. Yalavarthy
Phaneendra K. Yalavarthy
Phaneendra K. Yalavarthy
Professor
Department of Computational and Data Sciences, IISc
Personal website
Professor
Department of Computational and Data Sciences, IISc
Personal website
Professor
Department of Computational and Data Sciences, IISc
Personal website
Medical Principal Investigator
Medical Principal Investigator
Medical Principal Investigator
Krithika Rangarajan
Krithika Rangarajan
Krithika Rangarajan
Associate Professor
AIIMS, New Delhi
Associate Professor
AIIMS, New Delhi
Associate Professor
AIIMS, New Delhi
Team
Team
Team
Ashwin RaajKumar
Ashwin RaajKumar
Ashwin RaajKumar
Program Manager
Program Manager
Program Manager
Nidhi Sharma
Nidhi Sharma
Nidhi Sharma
Student Intern, IISc
Student Intern, IISc
Student Intern, IISc
Venkata Sai Manideep Nanepalli
Venkata Sai Manideep Nanepalli
Venkata Sai Manideep Nanepalli
Student Intern
Student Intern
Student Intern
Bharath Kumar Tangella
Bharath Kumar Tangella
Bharath Kumar Tangella
Student Intern
Student Intern
Student Intern
Mohan Kumar Manepalli
Mohan Kumar Manepalli
Mohan Kumar Manepalli
Student Intern
Student Intern
Student Intern
Partners & Collaborators
Partners & Collaborators
Get Involved
Get Involved
Get Involved
Glad to hear from potential partners, researchers, and collaborators.
Glad to hear from potential partners, researchers, and collaborators.
Glad to hear from potential partners, researchers, and collaborators.
Contact us at breastcancerdetection@tanuh.ai
Contact us at breastcancerdetection@tanuh.ai
Contact us at breastcancerdetection@tanuh.ai
The AI Centre of Excellence in Healthcare
AI Centre of Excellence in Healthcare
Indian Institute of Science
Seventh Floor, TCS Smart-X Hub
Bengaluru, India - 560 012
Email: info@tanuh.ai
Telephone: (080) 2293 4106 | (080) 2293 4107
Solutions
Oral Cancer Screening
Renal Health
2026 by TANUH
The AI Centre of Excellence in Healthcare
AI Centre of Excellence in Healthcare
Indian Institute of Science
Seventh Floor, TCS Smart-X Hub
Bengaluru, India - 560 012
Email: info@tanuh.ai
Telephone: (080) 2293 4106 | (080) 2293 4107
Solutions
Oral Cancer Screening
Renal Health
2026 by TANUH
The AI Centre of Excellence in Healthcare
AI Centre of Excellence in Healthcare
Indian Institute of Science
Seventh Floor, TCS Smart-X Hub
Bengaluru, India - 560 012
Email: info@tanuh.ai
Telephone: (080) 2293 4106 | (080) 2293 4107
Solutions
Oral Cancer Screening
Renal Health
2026 by TANUH